These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32697788)

  • 1. OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease.
    Tran HTL; Morikawa K; Anggakusuma ; Zibi R; Thi VLD; Penin F; Heim MH; Quadroni M; Pietschmann T; Gouttenoire J; Moradpour D
    PLoS One; 2020; 15(7):e0236447. PubMed ID: 32697788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease.
    Morikawa K; Gouttenoire J; Hernandez C; Dao Thi VL; Tran HT; Lange CM; Dill MT; Heim MH; Donzé O; Penin F; Quadroni M; Moradpour D
    Hepatology; 2014 Feb; 59(2):423-33. PubMed ID: 23929719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
    El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
    Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
    Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
    Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
    Morikawa K; Lange CM; Gouttenoire J; Meylan E; Brass V; Penin F; Moradpour D
    J Viral Hepat; 2011 May; 18(5):305-15. PubMed ID: 21470343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile.
    Martin MM; Condotta SA; Fenn J; Olmstead AD; Jean F
    Biol Chem; 2011 Oct; 392(10):927-35. PubMed ID: 21749281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors.
    Dultz G; Shimakami T; Schneider M; Murai K; Yamane D; Marion A; Zeitler TM; Stross C; Grimm C; Richter RM; Bäumer K; Yi M; Biondi RM; Zeuzem S; Tampé R; Antes I; Lange CM; Welsch C
    J Biol Chem; 2020 Oct; 295(40):13862-13874. PubMed ID: 32747444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication.
    Kang X; Chen X; He Y; Guo D; Guo L; Zhong J; Shu HB
    Virology; 2013 Jan; 435(2):385-94. PubMed ID: 23137809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase.
    Tallorin L; Villareal VA; Hsia CY; Rodgers MA; Burri DJ; Pfeil MP; Llopis PM; Lindenbach BD; Yang PL
    J Biol Chem; 2020 Aug; 295(35):12426-12436. PubMed ID: 32641492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry.
    Pillaiyar T; Namasivayam V; Manickam M
    Curr Med Chem; 2016; 23(29):3404-3447. PubMed ID: 27160539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
    Mawatari S; Uto H; Ido A; Nakashima K; Suzuki T; Kanmura S; Kumagai K; Oda K; Tabu K; Tamai T; Moriuchi A; Oketani M; Shimada Y; Sudoh M; Shoji I; Tsubouchi H
    PLoS One; 2013; 8(12):e82094. PubMed ID: 24349192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
    Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
    Hiscott J; Lacoste J; Lin R
    Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
    Li XD; Sun L; Seth RB; Pineda G; Chen ZJ
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17717-22. PubMed ID: 16301520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
    Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
    J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cell-based assay for monitoring hepatitis C virus ns3/4a protease activity.
    Lei YF; Yin W; Yang J; Lv X; Wei SH; An QX; Hu XB; Xu ZK
    Acta Virol; 2008; 52(3):133-41. PubMed ID: 18999887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.